Yacine Merrouche

4.0k total citations
103 papers, 2.5k citations indexed

About

Yacine Merrouche is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yacine Merrouche has authored 103 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Yacine Merrouche's work include Cancer Treatment and Pharmacology (14 papers), Cancer Diagnosis and Treatment (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yacine Merrouche is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Cancer Diagnosis and Treatment (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yacine Merrouche collaborates with scholars based in France, United States and Belgium. Yacine Merrouche's co-authors include Armand Bensussan, Christian Garbar, Jérôme Giustiniani, Sylvie Négrier, Thierry Lesimple, R. Bugat, Frank Antonicelli, Karim Fizazi, Jean‐Luc Raoul and Alain Lortholary and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Yacine Merrouche

100 papers receiving 2.4k citations

Peers

Countries citing papers authored by Yacine Merrouche

Since Specialization

Citations

This map shows the geographic impact of Yacine Merrouche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yacine Merrouche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yacine Merrouche more than expected).

Fields of papers citing papers by Yacine Merrouche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yacine Merrouche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yacine Merrouche. The network helps show where Yacine Merrouche may publish in the future.

Co-authorship network of co-authors of Yacine Merrouche

This figure shows the co-authorship network connecting the top 25 collaborators of Yacine Merrouche. A scholar is included among the top collaborators of Yacine Merrouche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yacine Merrouche. Yacine Merrouche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape 2018 ·Cancer Management and Research ·Christian Garbar, C. Mascaux, Yacine Merrouche, Armand Bensussan	9
2	The Interleukin-17 Family of Cytokines in Breast Cancer 2018 ·International Journal of Molecular Sciences ·(unknown), Jérôme Giustiniani, Christian Garbar, Yacine Merrouche, Frank Antonicelli, Armand Bensussan	52
3	A FOCUS ON IL-17 TARGETING TREATMENTS IN PSORIASIS 2016 ·Armand Bensussan, (unknown), Jérôme Giustiniani, (unknown), Yacine Merrouche, Martine Bagot	2
4	Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type 2016 ·International Journal of Molecular Sciences ·(unknown), Jérôme Giustiniani, Christian Garbar, Frank Antonicelli, Yacine Merrouche, Armand Bensussan, Martine Bagot, Reem Al‐Daccak	113
5	Évaluation du dépistage des cancers de la femme et du dépistage après 75 ans dans le département de la Loire 2014 ·Bulletin du Cancer ·Aurélie Swalduz, (unknown), Jane‐Chloé Trone, Jean-Baptiste Guichard, Romain Rivoirard, (unknown), Benoîte Méry, Jean‐Baptiste Guy, (unknown), P. Fournel, Guy de Laroche, Yacine Merrouche, Nicolas Magné	1
6	Radiotherapy for head and neck cancer in nonagenarian patients: a possible cornerstone? 2014 ·European Archives of Oto-Rhino-Laryngology ·Romain Rivoirard, Coralie Moncharmont, (unknown), Pierre Auberdiac, Benoîte Méry, Alexander T. Falk, Pierre Annède, Jane‐Chloé Trone, Jean‐Baptiste Guy, (unknown), P. Fournel, Yacine Merrouche, Cyrus Chargari, Nicolas Magné	8
7	Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06 2013 ·Targeted Oncology ·(unknown), Gilles Romieu, J Salvat, L. Chaigneau, Yacine Merrouche, Trang Huyen Thi Nguyen, Antoine Thiery-Vuillemin, Martin Demarchi, Erion Dobi, Xavier Pivot	9
8	Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study. 2011 ·PubMed ·Gilles Freyer, (unknown), G. Milano, Étienne Chatelut, Christine Rebischung, Jean‐Pierre Delord, Yacine Merrouche, Gérard Lledo, Marie‐Christine Etienne, Claire Falandry	14
9	Sarcoma of vulva, vagina and ovary 2011 ·Best Practice & Research Clinical Obstetrics & Gynaecology ·Nicolas Magné, (unknown), Pierre Auberdiac, Jean-Philippe Jacquin, Cyrus Chargari, Céline Chauleur, Christine Meder, Yacine Merrouche	21
10	Recommendations for a lifestyle which could prevent breast cancer and its relapse: Physical activity and dietetic aspects 2011 ·Critical Reviews in Oncology/Hematology ·Nicolas Magné, (unknown), Cyrus Chargari, Pierre Castadot, Jean-Baptiste Guichard, (unknown), Alice Nourissat, Rémy Largillier, Jean-Philippe Jacquin, Franck Chauvin, Yacine Merrouche	32
11	Cisplatine ou carboplatine, telle est la question 2011 ·Bulletin du Cancer ·Coralie Moncharmont, Pierre Auberdiac, (unknown), Saïd Afqir, (unknown), Cyrus Chargari, Yacine Merrouche, Nicolas Magné	17
12	Inflammatory breast cancer outcome with epirubicin‐based induction and maintenance chemotherapy 2006 ·Cancer ·Corinne Veyret, Christelle Lévy, P. Chollet, Yacine Merrouche, Henri Roché, Pierre Kerbrat, P. Fumoleau, P. Fargeot, P. Clavère, Bernard Chevallier	27
13	From Randomised Clinical Trials to Clinical Practice 2004 ·PharmacoEconomics ·Samuel Limat, Marie-Christine Woronoff-Lemsi, (unknown), Anne Madroszyk, Yacine Merrouche	12
14	[Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site]. 2002 ·PubMed ·R. Bugat, A Bataillard, Thierry Lesimple, Jean‐Jacques Voigt, Stéphane Culine, Alain Lortholary, Yacine Merrouche, G. Ganem, Marie‐Christine Kaminsky, Sylvie Négrier, M. Pérol, (unknown), Pierre Bédossa, G. Bertrand, Jean‐Michel Coindre, Karim Fizazi, (unknown)	17
15	Small-cell carcinoma of the esophagus: Report of three cases and review of the literature with emphasis on therapy 2001 ·Annals of Oncology ·A. Madroszyk, Joëlle Egreteau, Lance Martin, P Queneau, J.-F. Bosset, Yacine Merrouche	26
16	Restriction of the T-cell repertoire in tumor-infiltrating lymphocytes from nine patients with renal-cell carcinoma relevance of the CDR3 length analysis for the identification ofin situ clonal T-cell expansions 1996 ·International Journal of Cancer ·Isabelle Puisieux, Christine Bain, Yacine Merrouche, (unknown), Philippe Kourilsky, Jos Even, Marie Favrot	32
17	Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors 1995 ·Cancer Chemotherapy and Pharmacology ·G. Catimel, R. Coquard, (unknown), Yacine Merrouche, N Le Bail, (unknown), A Dumortier, (unknown), (unknown)	15
18	Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma 1994 ·British Journal of Cancer ·Alain Ravaud, Sylvie Négrier, Laurent Cany, Yacine Merrouche, M. Le Guillou, Jean‐Yves Blay, M. Clavel, Richard Gastón, R. Oskam, Thierry Philip	31
19	Intravenous interleukin-2 in patients over 65 with metastatic renal carcinoma 1992 ·British Journal of Cancer ·(unknown), A. Mercatello, (unknown), Philippe Thiesse, Jean‐Yves Blay, (unknown), Yacine Merrouche, R. Oskam, (unknown), M. Clavel, (unknown), Thierry Philip	15
20	Retroviral Gene Therapy and Its Application in Oncohematology 1992 ·Human Gene Therapy ·Yacine Merrouche, Marie Favrot	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact